BridgeBio Pharma, Inc. (BBIO) vs Corcept Therapeutics Incorporated (CORT)
- BridgeBio Pharma, Inc. BBIO 66.39 −1.10%
- Corcept Therapeutics Incorporated CORT 110.16 −2.83%
BridgeBio Pharma, Inc. and Corcept Therapeutics Incorporated are both Biotechnology companies. BridgeBio Pharma, Inc. and Corcept Therapeutics Incorporated are of similar size ($13.1B and $12.3B). BridgeBio Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 212×. BridgeBio Pharma, Inc. grew revenue faster over the last twelve months: 202.4% against 16.0%. Corcept Therapeutics Incorporated has the higher net margin (6.53% vs −97.0%) and the higher return on invested capital (1.01% vs 0.00%). Across the 18 metrics below, Corcept Therapeutics Incorporated leads on 12 and BridgeBio Pharma, Inc. on 6.
Valuation
Profitability
| Metric | BBIO | CORT | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.44% | 98.30% | 65.16% |
| Operating margin | (69.81%) | 0.77% | 0.00% |
| Net margin | (97.03%) | 6.53% | 0.00% |
| Free cash flow margin | (61.06%) | 12.87% | 0.00% |
| Return on equity | 32.31% | 8.08% | (56.36%) |
| Return on assets | (60.23%) | 6.41% | (48.04%) |
| Return on invested capital | 0.00% | 1.01% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack